Meng Xue

939 total citations
40 papers, 708 citations indexed

About

Meng Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Meng Xue has authored 40 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Meng Xue's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer-related gene regulation (8 papers). Meng Xue is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Cancer-related gene regulation (8 papers). Meng Xue collaborates with scholars based in China, United States and Hong Kong. Meng Xue's co-authors include Shujie Chen, Xian Wang, Wenwen Chen, Jianmin Si, Zizhen Zhang, Jing Zhong, Liangjing Wang, Hongchuan Jin, Sanchuan Lai and Yingying Hu and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Meng Xue

38 papers receiving 703 citations

Peers

Meng Xue
Meng Xue
Citations per year, relative to Meng Xue Meng Xue (= 1×) peers Pinglin Lai

Countries citing papers authored by Meng Xue

Since Specialization
Citations

This map shows the geographic impact of Meng Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xue more than expected).

Fields of papers citing papers by Meng Xue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xue. The network helps show where Meng Xue may publish in the future.

Co-authorship network of co-authors of Meng Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Xue. A scholar is included among the top collaborators of Meng Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Xue. Meng Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jie, et al.. (2025). m1A-regulated DIAPH3 promotes the invasiveness of colorectal cancer via stabilization of KRT19. Clinical & Experimental Metastasis. 42(2). 10–10. 1 indexed citations
2.
Ma, Jie‐Qiong, Hui Wang, Meng Xue, et al.. (2025). Role of super-enhancer-associated miRNAs and histone modifications in intramuscular fat deposition in yak. International Journal of Biological Macromolecules. 317(Pt 1). 144784–144784. 1 indexed citations
3.
Ji, Wenjie, Wenxue Zhao, Yan Xu, et al.. (2025). Shenling Kaixin granules attenuate depression via multi-target mechanisms: evidence from CSDS model and cellular studies. Phytomedicine. 149. 157547–157547.
4.
Chen, Wenwen, et al.. (2024). SUB1 promotes colorectal cancer metastasis by activating NF-κB signaling via UBR5-mediated ubiquitination of UBXN1. Science China Life Sciences. 67(6). 1199–1211. 1 indexed citations
5.
Li, Xiao, et al.. (2024). A genome-wide methylation analysis of Chinese Han patients with chronic insomnia disorder. Sleep And Breathing. 28(6). 2397–2407.
6.
Xue, Meng, et al.. (2023). [Neuroprotective effect of ginsenoside Re on drosophila model of Parkinson's disease].. PubMed. 48(7). 1927–1935. 1 indexed citations
7.
Xue, Meng, et al.. (2023). HIF-1α/METTL1/m7G axis is involved in CRC response to hypoxia. Biochemical and Biophysical Research Communications. 693. 149385–149385. 4 indexed citations
8.
Xue, Meng, Zhuo Wang, Jiaojiao Ni, et al.. (2022). METTL14 Regulates Intestine Cellular Senescence through m6A Modification of Lamin B Receptor. Oxidative Medicine and Cellular Longevity. 2022(1). 9096436–9096436. 9 indexed citations
9.
Zhang, Zizhen, Jiaojiao Ni, Jiawei Sun, et al.. (2022). ENO3 promotes colorectal cancer progression by enhancing cell glycolysis. Medical Oncology. 39(6). 80–80. 13 indexed citations
10.
Sun, Jiawei, et al.. (2021). ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer. International Journal of Biological Sciences. 17(12). 3048–3058. 27 indexed citations
11.
Zheng, Sheng, Jiafeng Wang, Ning Ding, et al.. (2021). Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer. Journal of Nanobiotechnology. 19(1). 381–381. 38 indexed citations
12.
Zhang, Zizhen, Fei Chen, Jing Zhong, et al.. (2021). GDC-0326 Enhances the Effects of 5-Fu in Colorectal Cancer Cells by Inducing Necroptotic Death. OncoTargets and Therapy. Volume 14. 2519–2530. 14 indexed citations
13.
He, Jiamin, Xingkang He, Lan Wang, et al.. (2020). HoxC6 Functions as an Oncogene and Isoform HoxC6-2 May Play the Primary Role in Gastric Carcinogenesis. Digestive Diseases and Sciences. 65(10). 2896–2906. 6 indexed citations
14.
Xue, Meng, Hanyun Zhang, Peiwei Li, et al.. (2018). Efficacy predictors of a 2-month exclusive enteral nutrition for inducing remission of active Crohn’s disease. European Journal of Clinical Nutrition. 72(8). 1183–1186. 2 indexed citations
15.
Zhao, Lingyu, Dongdong Tong, Meng Xue, et al.. (2017). MeCP2, a target of miR-638, facilitates gastric cancer cell proliferation through activation of the MEK1/2–ERK1/2 signaling pathway by upregulating GIT1. Oncogenesis. 6(7). e368–e368. 58 indexed citations
16.
Zhao, Lingyu, Yingxun Liu, Dongdong Tong, et al.. (2017). MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways. EBioMedicine. 16. 87–100. 66 indexed citations
17.
Chen, Xueqin, et al.. (2015). Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia. PLoS ONE. 10(7). e0133906–e0133906. 17 indexed citations
18.
Cui, Jie, Zhi Li, Ling-Bo Qian, et al.. (2013). Reducing the oxidative stress mediates the cardioprotection of bicyclol against ischemia-reperfusion injury in rats. Journal of Zhejiang University SCIENCE B. 14(6). 487–495. 13 indexed citations
19.
Zhong, Jing, Shujie Chen, Meng Xue, et al.. (2012). ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI3K and MAPK signaling pathways in gastric cancer. BMC Cancer. 12(1). 290–290. 46 indexed citations
20.
Wang, Xian, Shujie Chen, Meng Xue, et al.. (2011). Homeobox D10 Gene, a Candidate Tumor Suppressor, Is Downregulated through Promoter Hypermethylation and Associated with Gastric Carcinogenesis. Molecular Medicine. 18(3). 389–400. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026